Koers OHR Pharmaceutical Inc Nasdaq
Aandelen
US67778H2004
Biotechnologie & Medisch Onderzoek
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 1,38 mln. 1,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -12 mln. -11,05 mln. | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-
| K/w-verhouding 2024 * |
-
| Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 86,62% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,37% | 49,46 mld. | |
+1,55% | 42,58 mld. | |
+49,11% | 42,49 mld. | |
-4,22% | 29,09 mld. | |
+11,57% | 26,61 mld. | |
-21,00% | 18,64 mld. | |
+7,36% | 13,16 mld. | |
+28,30% | 12,55 mld. | |
+23,80% | 12,1 mld. |